Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate specific areas of the brain. It’s shown promise in treating obsessive-compulsive disorder (OCD), including cases that may not ...
Please provide your email address to receive an email when new articles are posted on . The estimated added effect of provocation was not significant for either condition. The findings have ...
With this expanded portfolio, our users can now choose the most appropriate coil for each specific patient, prioritizing comfort, treatment precision, and outcomes.” — Kerry Rome, SVP MagVenture, Inc.
This life-changing Health Canada-approved technology directly targets the brain circuits involved in OCD—without the side effects of medication. Patients tell us they feel like they’re finally getting ...
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
Some 30% to 40% of patients do not respond to medications for depression and obsessive-compulsive disorder (OCD), but half of them could be helped by a noninvasive in-office procedure. To mark ...
BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Uncontrollable, recurring thoughts and behaviors that characterize obsessive-compulsive disorder (OCD) are experienced by 2% to 3% of people. Yet standard treatments — exposure therapy and medicines ...
NEWPORT NEWS, Va., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers, one of the leading providers of mental health services in the United States, is now offering BrainsWay’s Deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback